Developer docs
API playgroundTry for free, no card

Search company profiles

Biomapas

Full company profile

uuid00097dg

Namestring
Biomapas
Legal namestring
UAB Biomapas
Websiteurl
biomapas.com
Company typeenum
Private
Founded yearint
2004
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersKaunas, Lithuania
HQ citystring
Kaunas
HQ countrystring
Lithuania
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, pharmacovigilance services, regulatory affairs consulting, medical information services, contract research organization
Industry6 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAD
Regulatory Affairs & Submissions FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Contract Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Clinical Research Services
TypeProfessional Services
Description

Full-service and Functional Service Provision (FSP) clinical research services including site monitoring, data management, patient recruitment, and clinical trial management across Phase I-IV studies.

biomapas.com
2Pharmacovigilance Services
TypeProfessional Services
Description

Comprehensive PV services including case processing, aggregate reporting, PSMF development, RMP writing, PV system setup, QPPV services, audits, and regulatory intelligence. Provided as standalone or integrated solutions.

biomapas.com
3Regulatory Affairs Services
TypeProfessional Services
Description

Regulatory strategy, dossier development, marketing authorization applications, lifecycle management, promotional material review, and local regulatory affairs support across EU, EAEU, and CIS regions.

biomapas.com
4Medical Information Services
TypeProfessional Services
Description

24/7 medical information contact center, medical writing, content creation, translation and localization services, and integrated PV-MI solutions.

biomapas.com
5Quality Assurance Services
TypeProfessional Services
Description

Export auditors who identify gaps and provide actionable solutions, GCP training, and inspection readiness training.

biomapas.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Project-based professional services pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is tailored to specific project requirements, scope, and geographic coverage. FSP models use activity-based pricing per country or region.

biomapas.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biomapas is a pan-European pharma services provider offering four core service lines — Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information — supported by Quality Assurance. The company delivers these as full-service or Functional Service Provision (FSP) outsourcing models to pharmaceutical and biotech clients across 70+ countries, with deep local expertise in the CEE, CIS, EAEU, and MENA regions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 150+ Marketing Authorizations obtained through National Procedures
+2 more records
Product overview1 text field

Biomapas is a pan-European pharma services provider offering four core services: Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information, supported by Quality Assurance. The company operates a platform-plus-modules architecture where the four core service lines serve as the foundation, supplemented by specialized modules including PV-MI Integrated Solutions (powered by Nexentria En3), Pharmacovigilance System Set-Up & QPPV, Safety Database (Veeva Vault Safety), Global Case Processing, Medical Monitoring, PSMF Development, RMP Development, EAEU QPPV Services, Local Pharmacovigilance Representation, Literature Screening, Pharmacovigilance Audits, Medical Inquiry Management, Medical Writing, Regulatory Strategy & Gap Analysis, Dossier Development, eCTD Compilation, Lifecycle Management, and training programs like GCP Training and Biomapas Academy. The portfolio also includes specialized outsourcing models (FSP, Affiliate-Based Outsourcing) and niche services (Early Phase Oncology, CSV for PV Systems, M&A Support).

Product and service1 record
1Clinical Research
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Biomapas utilizes Nexentria's En3 platform to power their integrated PV-MI solutions. This technology partnership enables unified pharmacovigilance and medical information workflows, providing global pharma and biotech clients with a single integrated system for case management, reporting, and oversight across 70+ countries.

Strategic tierCoreTypeTechnology or Integration
Description

Biomapas utilizes Veeva Vault Safety as their primary safety database for pharmacovigilance operations, supporting adverse event management, case processing, and regulatory submissions. The platform enables real-time oversight, role-based assignment, and medical review workflows.

3Delta PV
Strategic tierCoreTypeStrategic or Co-development Partner
Description

On August 4, 2025, Biomapas announced the acquisition of Delta PV, a trusted pharmacovigilance service provider headquartered in Istanbul, Turkey. This strategic acquisition expands Biomapas' PV capabilities and brings them closer to their goal of building a truly global platform in life sciences services.

biomapas.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized European-headquartered CRO and pharmacovigilance services provider with comparable service mix (clinical research, PV, regulatory) and similar enterprise pharma/biotech client base. The closest direct peer to Biomapas in scale and positioning.

TypeDirect peer
Description

Specialized pharmacovigilance and regulatory services provider serving pharma and biotech globally. Overlaps heavily with Biomapas' PV, QPPV, and regulatory offerings.

TypeDirect peer
Description

Regulatory affairs, pharmacovigilance, and quality management consulting firm now part of Cencora/World Courier. Directly competes in RA, PV, and MA lifecycle services.

TypeBroad incumbent
Description

Largest global CRO with comprehensive clinical, PV, regulatory, and real-world evidence services. Competes with Biomapas on enterprise pharma FSP and full-service awards at a much larger scale.

TypeBroad incumbent
Description

Top-tier global CRO offering clinical, laboratory, and post-approval/PV services. Competes for large multi-service outsourcing contracts that overlap with Biomapas' FSP offering.

TypeBroad incumbent
Description

Major global CRO with deep PV and regulatory affairs practice; competes for the same enterprise pharma client base across clinical and post-marketing services.

TypeBroad incumbent
Description

Biopharmaceutical services organization offering clinical and commercial services. Overlaps with Biomapas in clinical operations and post-marketing/PV services for large pharma.

TypeBroad incumbent
Description

Mid-to-large CRO focused on clinical development for emerging biopharma. Comparable in size segment and competitive set, though narrower in PV/regulatory breadth than Biomapas.

TypeBroad incumbent
Description

Mid-sized global CRO with strong CNS, oncology, and rare disease clinical operations. Comparable mid-tier CRO competitor for Biomapas' biotech client segment.

TypeEmerging player
Description

Specialized regulatory affairs and pharmacovigilance consultancy serving pharma across Europe. Smaller and more focused than Biomapas, but directly comparable service portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biomapas

Pharmaceutical Contract Research Servicesbiomapas.com

Biomapas firmographics

Firmographics
Name
Biomapas
Legal name
UAB Biomapas
Website
https://biomapas.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Biomapas industry classification

Industry
Product category
Pharmaceutical Contract Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAD
Regulatory Affairs & Submissions FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical research services
  • Pharmacovigilance services
  • Regulatory affairs consulting
  • Medical information services
  • Contract research organization

Where Biomapas is headquartered

Location

Headquarters

HQ city
Kaunas
HQ country
Lithuania
HQ region
Europe

Offices1 record

Markets served

Biomapas business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Research Services: Full-service and Functional Service Provision (FSP) clinical research services including site monitoring, data management, patient recruitment, and clinical trial management across Phase I-IV studies.
  2. Pharmacovigilance Services: Comprehensive PV services including case processing, aggregate reporting, PSMF development, RMP writing, PV system setup, QPPV services, audits, and regulatory intelligence. Provided as standalone or integrated solutions.
  3. Regulatory Affairs Services: Regulatory strategy, dossier development, marketing authorization applications, lifecycle management, promotional material review, and local regulatory affairs support across EU, EAEU, and CIS regions.
  4. Medical Information Services: 24/7 medical information contact center, medical writing, content creation, translation and localization services, and integrated PV-MI solutions.
  5. Quality Assurance Services: Export auditors who identify gaps and provide actionable solutions, GCP training, and inspection readiness training.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractProject-based professional services pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Biomapas product offering

Product offering

Core offering

Biomapas is a pan-European pharma services provider offering four core service lines — Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information — supported by Quality Assurance. The company delivers these as full-service or Functional Service Provision (FSP) outsourcing models to pharmaceutical and biotech clients across 70+ countries, with deep local expertise in the CEE, CIS, EAEU, and MENA regions.

Product overview

Biomapas is a pan-European pharma services provider offering four core services: Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information, supported by Quality Assurance. The company operates a platform-plus-modules architecture where the four core service lines serve as the foundation, supplemented by specialized modules including PV-MI Integrated Solutions (powered by Nexentria En3), Pharmacovigilance System Set-Up & QPPV, Safety Database (Veeva Vault Safety), Global Case Processing, Medical Monitoring, PSMF Development, RMP Development, EAEU QPPV Services, Local Pharmacovigilance Representation, Literature Screening, Pharmacovigilance Audits, Medical Inquiry Management, Medical Writing, Regulatory Strategy & Gap Analysis, Dossier Development, eCTD Compilation, Lifecycle Management, and training programs like GCP Training and Biomapas Academy. The portfolio also includes specialized outsourcing models (FSP, Affiliate-Based Outsourcing) and niche services (Early Phase Oncology, CSV for PV Systems, M&A Support).

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Research

Quantifiable outcome

  • 150+ Marketing Authorizations obtained through National Procedures
  • +2 more outcomes

Companies that use Biomapas

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Biomapas technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature3 records

Biomapas partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Nexentria (En3 Platform)coreTechnology or IntegrationBiomapas utilizes Nexentria's En3 platform to power their integrated PV-MI solutions. This technology partnership enables unified pharmacovigilance and medical information workflows, providing global pharma and biotech clients with a single integrated system for case management, reporting, and oversight across 70+ countries.
  • Veeva Systems (Vault Safety)coreTechnology or IntegrationBiomapas utilizes Veeva Vault Safety as their primary safety database for pharmacovigilance operations, supporting adverse event management, case processing, and regulatory submissions. The platform enables real-time oversight, role-based assignment, and medical review workflows.
  • Delta PVcoreStrategic or Co-development PartnerOn August 4, 2025, Biomapas announced the acquisition of Delta PV, a trusted pharmacovigilance service provider headquartered in Istanbul, Turkey. This strategic acquisition expands Biomapas' PV capabilities and brings them closer to their goal of building a truly global platform in life sciences services.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Biomapas competitors and assessment

Company assessment

Direct peers

  • Ergomed plc: Mid-sized European-headquartered CRO and pharmacovigilance services provider with comparable service mix (clinical research, PV, regulatory) and similar enterprise pharma/biotech client base. The closest direct peer to Biomapas in scale and positioning.
  • PrimeVigilance: Specialized pharmacovigilance and regulatory services provider serving pharma and biotech globally. Overlaps heavily with Biomapas' PV, QPPV, and regulatory offerings.
  • PharmaLex (Cencora): Regulatory affairs, pharmacovigilance, and quality management consulting firm now part of Cencora/World Courier. Directly competes in RA, PV, and MA lifecycle services.

Broad incumbents

  • IQVIA: Largest global CRO with comprehensive clinical, PV, regulatory, and real-world evidence services. Competes with Biomapas on enterprise pharma FSP and full-service awards at a much larger scale.
  • ICON plc: Top-tier global CRO offering clinical, laboratory, and post-approval/PV services. Competes for large multi-service outsourcing contracts that overlap with Biomapas' FSP offering.
  • Parexel International: Major global CRO with deep PV and regulatory affairs practice; competes for the same enterprise pharma client base across clinical and post-marketing services.
  • Syneos Health: Biopharmaceutical services organization offering clinical and commercial services. Overlaps with Biomapas in clinical operations and post-marketing/PV services for large pharma.
  • Medpace Holdings: Mid-to-large CRO focused on clinical development for emerging biopharma. Comparable in size segment and competitive set, though narrower in PV/regulatory breadth than Biomapas.
  • Worldwide Clinical Trials: Mid-sized global CRO with strong CNS, oncology, and rare disease clinical operations. Comparable mid-tier CRO competitor for Biomapas' biotech client segment.

Emerging players

  • Arriello: Specialized regulatory affairs and pharmacovigilance consultancy serving pharma across Europe. Smaller and more focused than Biomapas, but directly comparable service portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Biomapas social profiles

Digital presence

Biomapas financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biomapas leadership team

Management profile

Number of profiles

Profiles8 records

Biomapas subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Biomapas funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biomapas M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomapas

What does Biomapas do?

Biomapas is a pan-European pharma services provider offering four core service lines — Clinical Research, Regulatory Affairs, Pharmacovigilance, and Medical Information — supported by Quality Assurance. The company delivers these as full-service or Functional Service Provision (FSP) outsourcing models to pharmaceutical and biotech clients across 70+ countries, with deep local expertise in the CEE, CIS, EAEU, and MENA regions.

Is Biomapas a public or private company?

Biomapas is a private company. It is classified as private equity controlled and is currently operating.

When was Biomapas founded?

Biomapas was founded in 2004. It employs 251 to 500 people.

Where is Biomapas based?

Biomapas is headquartered in Kaunas, Lithuania, in the Europe region.

How does Biomapas make money?

Five revenue lines are on record. Clinical Research Services are the primary driver. The others are pharmacovigilance Services, regulatory Affairs Services, medical Information Services and quality Assurance Services.

Who are Biomapas's main competitors?

Direct peers on record are Ergomed plc, PrimeVigilance and PharmaLex (Cencora). Broad incumbents are IQVIA, ICON plc, Parexel International, Syneos Health, Medpace Holdings and Worldwide Clinical Trials. Arriello is listed as an emerging player.

Does Biomapas have an API?

No public API is recorded for Biomapas.

What industry is Biomapas in?

Biomapas's product category is Pharmaceutical Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PharmExecDoing More With Less: How Automation is Reshaping Drug SafetyPharmacovigilance teams are increasingly adopting cloud-based automation and outsourcing to specialized CROs to manage rising adverse event reporting volumes and complex regulatory requirements. Biomapas serves as a primary example of a company transitioning from manual, siloed processes to a cloud-based safety database to enhance data security, real-time access, and operational flexibility. This industry shift aims to reduce administrative burdens on specialists, allowing them to focus on patient safety and cross-functional collaboration in line with World Health Organization goals.BiomapasBiomapas Acquires Delta PV to Expand Pharmacovigilance CapabilitiesBiomapas acquired Delta PV, a pharmacovigilance service provider based in Istanbul, Turkey. The deal expands Biomapas' global safety capabilities across Europe, CIS, APAC, and MENA, with Delta PV bringing automated safety data monitoring. The acquisition follows Carbyne Equity Partners' strategic investment in Biomapas.BiomapasM&A SupportThe article is a promotional overview of M&A support services offered by Biomapas, a clinical research organization. It details how the company assists clients with due diligence, regulatory compliance, and post-merger integration to ensure smooth transitions during acquisitions. The text emphasizes personalized approaches and long-term partnerships rather than reporting on a specific completed transaction.Grand View ResearchMiddle East Biopharmaceutical Contract Research Organization Market, 2033The Middle East biopharmaceutical contract research organization (CRO) market is projected to grow from USD 875.4 million in 2024 to USD 1,736.5 million by 2033, driven by expanding clinical trial infrastructure and rising disease prevalence. Recent strategic developments include Biomapas' acquisition of Delta PV to enhance regional capabilities and a collaboration between KAIMRC and Flagship Pioneering to accelerate therapeutic development in Saudi Arabia.BiomapasCase Study CSVBiomapas published a case study describing its validation of a cloud-based pharmacovigilance safety database for a mid-sized EU pharmaceutical company. The team validated five releases within two months, identifying risks including GAMP 5 categorization, unvalidated bug fixes and missing validation for medium-impact features. They ran user acceptance testing for Release 1 and Release 5, reviewing over 1,500 release notes.PrwebBiomapas CRO Welcomes New Project DirectorBiomapas, a European CRO, hired Nidas Jurjonas, MD, as Project Director. He brings over 20 years of pharmaceutical industry experience, including prior roles at Novartis. The role involves managing full-scale projects for pharmaceutical, medical device, and biotechnology companies.